Breaking News Instant updates and real-time market news.

SPOT

Spotify

$193.79

2.34 (1.22%)

, P

Pandora

$8.03

0.16 (2.03%)

17:19
08/14/18
08/14
17:19
08/14/18
17:19

Soros takes new stakes in Spotify and Pandora, adds to NXP Semi

George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of June 30, 2018. Soros' new buys during the second quarter included, by size of position, Spotify (SPOT), Pandora (P), Coupa Software (COUP), Facebook (FB), and Devon Energy (DVN). Soros exited positions during the quarter, including by size of previous position, Kennedy-Wilson (KW), Lam Research (LRCX), Alerian MLP (AMLP), Zayo Group (ZAYO) and Baxter International (BAX). Soros increased his stake in NXP Semi (NXPI), XL Group (XL), Intelsat (I), LPL Financial (LPLA) and ServiceNow (NOW). Soros reduced its stake in FGL Holdings (FG), Netflix (NFLX), EQT Corp (EQT), and Williams (WMB).

SPOT

Spotify

$193.79

2.34 (1.22%)

P

Pandora

$8.03

0.16 (2.03%)

COUP

Coupa Software

$67.68

2.14 (3.27%)

FB

Facebook

$181.11

1.03 (0.57%)

DVN

Devon Energy

$42.41

0.35 (0.83%)

KW

Kennedy Wilson

$21.40

-0.05 (-0.23%)

LRCX

Lam Research

$176.69

-1.44 (-0.81%)

ZAYO

Zayo Group

$37.64

0.15 (0.40%)

BAX

Baxter

$70.70

-0.01 (-0.01%)

NXPI

NXP Semiconductors

$91.21

-1.92 (-2.06%)

XL

XL Group

$56.37

0.01 (0.02%)

I

Intelsat

$22.99

0.195 (0.86%)

LPLA

LPL Financial

$65.92

0.96 (1.48%)

NOW

ServiceNow

$184.51

-0.53 (-0.29%)

FG

FGL Holdings

$9.33

0.065 (0.70%)

NFLX

Netflix

$337.49

-3.79 (-1.11%)

EQT

EQT Corporation

$50.34

0.98 (1.99%)

WMB

Williams

$30.32

-0.36 (-1.17%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 28

    Aug

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 31

    Oct

SPOT Spotify
$193.79

2.34 (1.22%)

07/27/18
RILY
07/27/18
NO CHANGE
Target $200
RILY
Neutral
Spotify price target raised to $200 from $156 at B. Riley FBR
B. Riley FBR analyst Barton Crockett raised his price target for Spotify Technology to $200 after updating his estimates following the company's Q2 results. The analyst reiterates a Neutral rating on the shares.
07/27/18
WELS
07/27/18
NO CHANGE
Target $180
WELS
Market Perform
Spotify price target raised to $180 from $150 at Wells Fargo
Wells Fargo analyst Peter Stabler raised his price target for Spotify Technology to $180 saying the company posted an in-line quarter that featured premium subscriber growth at the high end of guidance. The analyst, however, keeps a Market Perform rating on the shares citing valuation.
07/27/18
STFL
07/27/18
NO CHANGE
Target $225
STFL
Buy
Spotify price target raised to $225 from $200 at Stifel
Stifel analyst John Egbert said Spotify's Q2 results show the company's continued momentum along with "no discernable impact" from competition. He now expects Spotify to add more net subscribers in 2018 than 2017, adding that the company's peak subscriber growth year could still be ahead of it. Egbert, who raised his subscriber and gross margin forecasts for 2018 and 2019, increased his price target on Spotify to $225 from $200 and keeps a Buy rating on the shares.
07/30/18
BOFA
07/30/18
NO CHANGE
Target $230
BOFA
Buy
Spotify price target raised to $230 from $195 at BofA/Merrill
BofA/Merrill analyst Jessica Reif raised her price target on Spotify to $230 after the company's Q2 results that showed improving subscription gains offset in part by "softer" average revenue per user and "lighter" monthly active user count. The analyst is also positive on Spotify's stable geographic diversification of sales and a "high rate of programmatic and premium video advertising growth of 44% and 28%". Reif kept her Buy rating on Spotify, anticipating continued MAU growth driven by emerging markets expansion, Family Plan adoption, and growth in historically physical markets.
P Pandora
$8.03

0.16 (2.03%)

08/02/18
MKMP
08/02/18
NO CHANGE
Target $8
MKMP
Neutral
Pandora price target raised to $8 at MKM Partners
MKM Partners analyst Rob Sanderson raised his price target on Pandora to $8 from $6.25 after its "modestly better than consensus" Q2 EBITDA loss and a revenue beat. The analyst keeps also his Neutral rating, noting that the company's user base continues to decline. Sanderson adds that there is little visibility into Pandora's outlook regarding subscription vs. ad-supported revenue mix, the impact of "marketing reallocation" with respect to its user growth, and the uncertainties around cost of content and minimum guarantees.
08/01/18
08/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoZone (AZO) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker saying Improving comps and fundamentals, coupled with a stock that has underperformed year-to-date, has brought a "compelling" valuation. 2. Pandora (P) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the company's double-digit organic revenue growth and declining EBITDA losses were driven by improving execution, adding that while the 2% active listener hours decline is a worry, the valuation on the stock is "undemanding" given its expected annualized revenue growth of about 10% over the next 3 years. 3. Papa John's (PZZA) upgraded to Buy from Hold at Jefferies with analyst Alexander Slagle saying the stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving. 4. Electronic Arts (EA) upgraded to Buy from Hold at Argus with analyst Joseph Bonner saying the latest pullback in the stock price after the company's recent Q1 earnings report offers a favorable entry point. 5. Sarepta (SRPT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying the stock is down about 34% since June 19 after having moved up by about 50% when its initial DMD gene therapy data was announced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/18
BRRR
08/01/18
UPGRADE
Target $11
BRRR
Outperform
Pandora upgraded to Outperform from Market Perform at Barrington
Barrington analyst James Goss upgraded Pandora Media to Outperform with an $11 price target. The company has amassed a "huge" listener base and now expanded its audio services to encompass two levels of pay products, Goss tells investors in a research note after Pandora beat Q2 expectations for revenue and EBITDA. The analyst believes Pandora's strategy is beginning to come together.
08/01/18
ADAM
08/01/18
NO CHANGE
Target $10
ADAM
Buy
Pandora results show strong engagement and monetization, says Canaccord
Canaccord analyst Maria Ripps said Pandora's Q2 results shows there is strength in engagement and monetization and consistent progress relative to management's ongoing turnaround plan. Both advertising and subscription revenues were ahead of expectations, noted Ripps, who reiterated her Buy rating and $10 price target on Pandora shares.
COUP Coupa Software
$67.68

2.14 (3.27%)

06/05/18
NEED
06/05/18
NO CHANGE
Target $63
NEED
Buy
Coupa Software price target raised to $63 from $55 at Needham
Needham analyst Peter Levine raised his price target for Coupa Software to $63 saying the company night reported a "solid" Q1 beat with 40% subscription growth. The analyst keeps a Buy rating on the shares.
06/18/18
BTIG
06/18/18
DOWNGRADE
BTIG
Neutral
Coupa Software downgraded to Neutral from Buy at BTIG
BTIG analyst Joel Fishbein downgraded Coupa Software to Neutral from Buy, saying the company's rise in valuation to 13.5-times enterprise value to expected FY19 revenues has separated it from its peers. The analyst remains positive on the company's long term opportunity, particularly in Asia, and expects the investment story to become more centered around its international expansion potential. However, at its current levels, Fishbein sees the risk-reward on Coupa Software as balanced.
07/18/18
RBCM
07/18/18
NO CHANGE
Target $71
RBCM
Outperform
Coupa Software price target raised to $71 from $61 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Coupa Software to $71 and kept his Outperform rating following meetings with its CFO, saying the company offers a "long-term growth opportunity, unit economics and strength of execution". Among the "vectors of growth", MacMillan points to the international segment given the company's under-representation in APAC and LATAM, the federal government work, and the mid-market, where the the company is trying new initiatives such as website enhancements to improve lead qualification.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
FB Facebook
$181.11

1.03 (0.57%)

08/06/18
STFL
08/06/18
NO CHANGE
Target $202
STFL
Buy
Facebook added to Stifel Select List, Amazon removed
Stifel analyst Scott Devitt replaced Amazon (AMZN) with Facebook (FB) on the Stifel Select List, citing the strong year-to-date performance of Amazon shares, which he still likes and keeps a Buy rating upon. He believes Facebook expectations, and the shares, are appropriately set to allow for longer-term outperformance given the material reset that followed the company's "painful" Q2 update, Devitt tells investors. He maintains a Buy rating and $202 price target on Facebook.
08/09/18
BMOC
08/09/18
NO CHANGE
Target $52
BMOC
Outperform
Match Group price target raised to $52 from $45 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Match Group (MTCH) to $52 after its Q2 earnings beat and raised FY18 guidance, saying its Tinder platform continues to exceed expectations while the rest of the portfolio shows stability. Salmon adds that Tinder's subscription growth and pricing power position Match Group as a "sustainable long-term" story within the expanding total addressable market, even as the entry of Facebook (FB) into the online dating industry gets closes. The analyst keeps his Outperform rating on Match Group.
08/08/18
CHLM
08/08/18
NO CHANGE
Target $28
CHLM
Sell
Applied Optoelectronics price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $28 from $20 following a "strong" Q2 result, driven by strong upside from Data Center, specifically Facebook (FB). The analyst thinks most of the upside was from lack of supply from a competitor he believes to be Intel (INTC). He reiterates a Sell rating on Applied Optoelectronics shares.
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
DVN Devon Energy
$42.41

0.35 (0.83%)

08/06/18
UBSW
08/06/18
UPGRADE
Target $53
UBSW
Buy
Devon Energy upgraded to Buy from Neutral at UBS
UBS analyst Lloyd Byrne upgraded Devon Energy (DVN) to Buy and raised his price target for the shares to $53 from $45. Devon continues to take positive steps by focusing its inventory on its highest return assets, divesting EnLink (ENLK, ENLC) at a better than expected price, and having a material repurchase plan, Byrne tells investors in a research note. The analyst finds the stock's risk/reward as "compelling" at current levels. He sees 23% potential upside in the shares.
07/24/18
MZHO
07/24/18
INITIATION
Target $173
MZHO
Buy
Mizuho names 'Apple of oil' EOG top pick in Oil & Gas sector
Mizuho analyst Paul Sankey last night initiated 10 names in the Global Oil & Gas group with five buys, four neutrals and one underperform. He also maintained a Buy rating on Occidental Petroleum (OXY) and Neutral rating on ConocoPhillips (COP). The analyst put Buy ratings on EOG Resources (EOG), his top pick in the group, Anadarko Petroleum (APC), Pioneer Natural Resources (PXD), Noble Energy (NBL) and Suncor (SU). Sankey calls EOG the Apple (AAPL) of oil. The company has been a pioneer in unconventional oil development in the U.S. and its technology-driven, innovation-focused approach will continue to drive peer-leading rates of return and oil growth, the analyst contends. He put Neutral ratings on Devon Energy (DVN), Hess Corp. (HES), Marathon Oil (MRO) and Apache (APA). Lastly, Sankey initiated Murphy Oil (MUR) with an Underperform rating and $36 price target. While the stock trades well below peers on both mid-cycle free cash and discount to net asset value, there is not enough potential upside to justify a Neutral at this point, Sankey told investors in a research note.
07/23/18
MZHO
07/23/18
INITIATION
Target $59
MZHO
Buy
Devon Energy initiated with a Buy at Mizuho
Mizuho analyst Paul Sankey started Devon Energy with a Buy rating and $59 price target.
07/12/18
MSCO
07/12/18
INITIATION
Target $46
MSCO
Equal Weight
Devon Energy initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analysts Devin McDermott and Drew Venker added coverage of 12 large-cap and diversified E&Ps, including Devon Energy, which they started with a $46 price target and Equal Weight rating.
KW Kennedy Wilson
$21.40

-0.05 (-0.23%)

10/30/17
DBAB
10/30/17
INITIATION
Target $23
DBAB
Hold
Kennedy Wilson resumed with a Hold at Deutsche Bank
Deutsche Bank analyst Vin Chao resumed coverage of Kennedy Wilson with a Hold rating and lowered his price target for the shares to $23 from $27.
03/09/18
JMPS
03/09/18
UPGRADE
JMPS
Outperform
Kennedy Wilson upgraded to Outperform from Market Perform at JMP Securities
03/09/18
03/09/18
UPGRADE
Target $22

Outperform
Kennedy Wilson upgraded after ' transformative' 2017 at JMP Securities
As previously reported, JMP Securities analyst Mitch Germain upgraded Kennedy Wilson to Outperform from Market Perform, stating that he has greater conviction following the company's "transformative campaign" in 2017. The completed merger with its European partner has created a more stable cash flow profile, while share buybacks, a compensation plan revision, and de-leveraging are all potential catalysts, he tells investors. Germain set a $22 price target on Kennedy Wilson shares.
05/04/18
BOFA
05/04/18
NO CHANGE
BOFA
Zendesk, Kennedy Wilson added to Endeavor List at BofA/Merrill
LRCX Lam Research
$176.69

-1.44 (-0.81%)

07/27/18
UBSW
07/27/18
NO CHANGE
Target $220
UBSW
Buy
Lam Research quarter marks the bottom, says UBS
UBS analyst Timothy Arcuri noted Lam Research is enduring a healthy correction, but he believes this quarter marked the bottom. Arcuri sees s snap back in revenue moving forward and reiterated his Buy rating and $220 price target on Lam Research shares.
08/13/18
STFL
08/13/18
NO CHANGE
STFL
Buy
3D NAND benefits equipment suppliers, advanced materials, says Stifel
Stifel analyst Patrick Ho tells investors in a research note that, following last week's Flash Memory Summit, the transition by the NAND industry to 96 layers and above will be the catalyst for a further step up in capital intensity trends for materials-enabled processes. He believes the comments and presentations that emerged from the conference continue to support his favorable view on names like Applied Materials (AMAT), KLA-Tencor (KLAC), Lam Reserach (LRCX) and MKS Instruments (MKSI), but believes another group that will benefit are materials/chemistries companies like Entegris (ENTG) and Versum Materials (VSM).
08/09/18
08/09/18
DOWNGRADE
Target $54

Equal Weight
Morgan Stanley more cautious on semi equipment, downgrades Applied Materials
As previously reported, Morgan Stanley analyst Joseph Moore downgraded Applied Materials (AMAT) to Equal Weight from Overweight, as he said he is concerned by the fact that the certainty of semiconductor capital equipment vendors "seems much higher than the conviction of the spenders." He would expect Applied Materials to express a sense of optimism about the recovery when it reports earnings next week, similar to the June quarters from equipment vendors, which he said should help the stock. However, Moore views the first quarter of 2018 as the peak and forecasts declines of about 10% next year. He lowered his price target on Applied shares to $54 from $58. Moore, who sees equipment stocks as more range-bound for the next 6-12 months, also lowered his semiconductor capital equipment industry view to In-Line from Attractive.
08/06/18
STFL
08/06/18
NO CHANGE
STFL
Stifel says Applied, Lam to be beneficiaries of NAND capital intensity step-up
Ahead of this week's upcoming Flash Memory Summit, Patrick Ho shared his view of how he expects capital intensity trends continue to increase as the NAND industry moves to 96 layers and above over the next few years. From a stocks perspective, he believes the biggest beneficiaries of the step-up will remain Applied Materials (AMAT) and Lam Research (LRCX), while also noting that MKS Instruments (MKSI) can benefit from its leadership position in many areas where it supplies both Applied and Lam. Stating that he supports Ho's view on the memory industry's increasing capital intensity, Stifel analyst Kevin Cassidy said in his own note to investors that he expects FMS conference keynotes to discuss the expanding markets for NAND Flash pushing total revenue and profits up despite the industry's increasing capital expenditures driving average selling prices lower. Cassidy also noted the first ever MRAM Developers Day will be held Monday, August 6, stating that he views this as significant for expanding the MRAM eco-system led by Everspin (MRAM). Other NAND Flash names Cassidy has previously been positive about include Micron (MU) and Smart Global (SGH).
ZAYO Zayo Group
$37.64

0.15 (0.40%)

05/18/18
BOFA
05/18/18
INITIATION
Target $43
BOFA
Buy
Zayo Group initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Joshua Frantz initiated Zayo Group with a Buy and $43 price target citing strong broadband secular tailwinds, a shifting market structure that provides opportunity, recent salesforce reorganization, reduced churn, upside from potential REIT conversion.
05/04/18
DBAB
05/04/18
NO CHANGE
DBAB
Buy
Zayo Group positives outweigh the negatives, says Deutsche Bank
Deutsche Bank analyst Matthew Niknam believes the positives outweigh the negatives in Zayo Group's Q3 results. While the results had something for both bulls and bears, the positives outweigh the negatives, and are ultimately more impactful for the forward stock trajectory, Niknam tells investors in a research note. He believes Zayo shares offer a "high quality blend of accelerating underlying growth, strategic asset value, and upside optionality catalysts." The analyst keeps a Buy rating on the name.
04/18/18
DBAB
04/18/18
UPGRADE
Target $42
DBAB
Buy
Zayo Group upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matthew Niknam upgraded Zayo Group to Buy and raised his price target for the shares to $42 from $37. The analyst sees improving fundamentals as he believes Zayo has moved past the recent operational headwinds. Zayo offers inflecting fundamentals with "optionality abound," Niknam tells investors in a research note.
05/04/18
COWN
05/04/18
NO CHANGE
Target $44
COWN
Outperform
Zayo Group weakness a buying opportunity, says Cowen
Cowen analyst Colby Synesael noted Zayo reported disappointing Q3 headline results, which was driven by a greater churn in Allstream as well as a variety of one-time adjustments. He does not believes the departure of the COO will derail momentum and cited the plans for the company's transition to a REIT. He believes any selloff in the shares will be short-lived. Synesael reiterated his Outperform rating and raised his price target to $44 from $43 on Zayo Group shares.
BAX Baxter
$70.70

-0.01 (-0.01%)

07/26/18
PIPR
07/26/18
NO CHANGE
Target $83
PIPR
Overweight
Baxter price target raised to $83 from $77 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target on Baxter to $83 after its Q2 earnings beat and raised FY18 EPS guidance. The analyst further notes that in addition to continued margin improvement, investors may be "overlooking revenue growth opportunities". O'Brien keeps his Overweight rating on Baxter despite the 4% stock price decline from the headwinds in Medication Delivery and Nutrition, and believes the guidance provided by the management is on the conservative site, with "large share appreciation from potential capital deployment this year".
05/17/18
PIPR
05/17/18
INITIATION
Target $77
PIPR
Overweight
Baxter assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien assumed coverage of Baxter International with an Overweight rating and $77 price target. Management has done an "excellent job" in quickly turning the company around, O'Brien tells investors in a research note. He believes there is further gross margin expansion available to push earnings higher and that the company's "clean" balance sheet should provide opportunity to do an accretive deal.
05/17/18
05/17/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Costco (COST) initiated with a Buy at Loop Capital. 2. Align Technology (ALGN) initiated with an Outperform at Evercore ISI. 3. Baxter (BAX) assumed with an Overweight at Piper Jaffray. 4. Comtech (CMTL) initiated with a Neutral at Citi. 5. Helius Medical (HSDT) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/18
PIPR
05/22/18
NO CHANGE
Target $77
PIPR
Overweight
Baxter buybacks should push shares higher, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says the long-term guidance Baxter announced yesterday at its analyst meeting is essentially in-line with expectations. The key takeaways are the innovation Baxter is delivering, with $1.7B in new products expected over the next five years, and its "sizable" free cash flow, O'Brien tells investors in a research note. The cash flow will allow the company to execute accretive deals or share repurchases, conceivably as much as 20% of outstanding stock, the analyst adds. He believes this could push shares higher in the coming quarters and keeps an Overweight rating on Baxter with a $77 price target. O'Brien encourages investors to start or build positions in the name.
NXPI NXP Semiconductors
$91.21

-1.92 (-2.06%)

08/02/18
08/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Magnolia Oil & Gas (MGY) initiated with a Buy at SunTrust. 2. VICI Properties (VICI) initiated with a Neutral at Citi. 3. Cision (CISN) initiated with a Buy at Citi. 4. Allena Pharmaceuticals (ALNA) initiated with a Buy at Ladenburg. 5. NXP Semiconductors (NXPI) reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/18
MZHO
08/14/18
NO CHANGE
MZHO
Buy
ON Semiconductor pullback a buying opportunity, says Mizuho
Mizuho analyst Vijay Rakesh views the recent pullback in shares of ON Semiconductor (ON) as a buying opportunity. The analyst attributes the selloff to concerns of a peaking semi cycle, but points out that over the last four-years, ON's exposure to auto and industrial revenue has almost doubled. However, the stock trades at a 50% discount to automotive and industrial peers including Texas Instruments (TXN), NXP Semiconductors (NXPI), Analog Devices (ADI), Maxim Integrated (MXIM) and Monolithic Power (MPWR), Rakesh tells investors in a research note.
07/30/18
NEED
07/30/18
NO CHANGE
Target $120
NEED
Strong Buy
NXP Semiconductors price target lowered to $120 from $130 at Needham
Needham analyst Rajvindra Gill lowered his price target on NXP Semiconductors (NXPI) to $120 to reflect last week's sell-off that followed its earnings, buyback, and terminated Qualcomm (QCOM) deal. The analyst also keeps his Strong Buy rating and believes that investors will re-evaluated the shares, given that the company's revenue mix is much healthier on combination of auto, industrial and internet of things end markets, while the revenues lost from ZTE (ZTCOY) component import ban should resume in Q3.
08/02/18
LEHM
08/02/18
INITIATION
Target $100
LEHM
Equal Weight
NXP Semiconductors reinstated with an Equal Weight at Barclays
Barclays analyst Blayne Curtis reinstated coverage of NXP Semiconductors with an Equal Weight rating and $100 price target. The analyst sees "too much uncertainty on the top and bottom line" for a more constructive rating at this time. He believes NXP shares will trade at a discount to "higher quality" analog peers.
XL XL Group
$56.37

0.01 (0.02%)

05/08/18
05/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comcast (CMCSA) downgraded to Neutral from Overweight at Atlantic Equities. 2. Zillow (Z, ZG) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Mahaney citing the recent stock price appreciation. 3. XL Group (XL) downgraded to Sector Perform from Outperform at RBC Capital with analyst Mark Dwelle saying the company's first quarter earnings did not contain any red flags around the sale of the company to AXA (AXAHY), which is on track to close in late second quarter or in the third quarter. 4. Ionis Pharmaceuticals (IONS) downgraded to In Line from Outperform at Evercore ISI with analyst Josh Schimmer citing the safety concerns around volanesorsen discussed in the latest FDA briefing documents, which also "dismantled the company's claims" that the treatment leads to benefits in pancreatis. 5. Sapiens (SPNS) downgraded to Market Perform from Outperform at William Blair with analyst Justin Furby saying consensus estimates for 2019 could be a "too aggressive." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/18
LEHM
04/02/18
DOWNGRADE
Target $58
LEHM
Equal Weight
XL Group downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Jay Gelb downgraded XL Group (XL) to Equal Weight while raising his price target for the shares to $58 from $50 to reflect the takeover by AXA (AXAHY).
05/08/18
RBCM
05/08/18
DOWNGRADE
RBCM
Sector Perform
XL Group downgraded to Sector Perform from Outperform at RBC Capital
05/08/18
RBCM
05/08/18
DOWNGRADE
Target $57
RBCM
Sector Perform
XL Group downgraded to Sector Perform from Outperform at RBC CapitalAXA
As reported earlier, RBC Capital analyst Mark Dwelle downgraded XL Group (XL) to Sector Perform from Outperform but raised his price target to $57 from $46. The analyst notes that the company's Q1 earnings did not contain any red flags around the sale of the company to AXA (AXAHY), which is on track to close in late Q2 or in Q3. Dwelle adds that his new rating is an indication of low probability of a competitive bidder emerging.
I Intelsat
$22.99

0.195 (0.86%)

06/01/18
MSCO
06/01/18
NO CHANGE
Target $6
MSCO
Underweight
Intelsat price target raised to $6 from $1 at Morgan Stanley
Morgan Stanley analyst Simon Flannery noted that at a recent tower show FCC Chairman Ajit Pai announced his intention to introduce a C-band Notice of Proposed Rulemaking at the Commission's July 12 meeting, adding that the agenda for that meeting is expected June 21. While Flannery expects the FCC will be generally supportive of the joint spectrum sharing proposal being made by Intelsat (I) and Intel (INTC), he said "the devil is in the details" and that the C-band opportunity does not displace the secular pressures on Intelsat's organic business. Flannery is raising his Intelsat valuation to reflect the increased likelihood of spectrum monetization and increased his price target on the stock to $6 from $1, but he maintains an Underweight rating on the stock given the ongoing pressures in the satellite business.
06/20/18
RBCM
06/20/18
UPGRADE
RBCM
Outperform
Intelsat upgraded to Outperform from Sector Perform at RBC Capital
06/20/18
RBCM
06/20/18
UPGRADE
Target $30
RBCM
Outperform
Intelsat upgraded to Outperform at RBC Capital on expected FCC NPRM draft
As reported earlier, RBC Capital analyst Wilton Fry upgraded Intelsat to Outperform from Sector Perform and raised his price target to $30 from $5. Fry cites his expected FCC release of the Notice of Proposed Rulemaking this week that will lead to adoption of the company's C-band proposal, "conservatively" estimating that this could add over $19 in earnings per share. The analyst adds that the company's recent equity and convertible debt issuance "enabled Intelsat to break the captive nature of some of its debt instruments, leaving a pathway to refinance until 2023".
06/20/18
06/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Citi (C) upgraded to Buy from Hold at Deutsche Bank. 2. BT Group (BT) upgraded to Buy from Hold at Jefferies with analyst Jeremy Dellis saying reducing the dividend to increase investment in fiber-to-the-premises networks to satisfy demands by British telecommunications regulator Ofcom could make BT a "geat deal more investable." 3. Duke Energy (DUK) upgraded to Buy from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith citing recent share underperformance and resolved regulatory overhangs. 4. Glatfelter (GLT) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover saying he is "incrementally positive" on the stock based on his view of the announced acquisition of GP's European airlaid nonwoven business, which adds 35K tonnes per year in capacity to the company's existing 129K tpy. 5. Intelsat (I) upgraded to Outperform from Sector Perform at RBC Capital with analyst Wilton Fry citing his expected FCC release of the Notice of Proposed Rulemaking this week that will lead to adoption of the company's C-band proposal, "conservatively" estimating that this could add over $19 in earnings per share. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LPLA LPL Financial
$65.92

0.96 (1.48%)

05/08/18
FBCO
05/08/18
NO CHANGE
Target $92
FBCO
Outperform
LPL Financial price target raised to $92 from $84 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for LPL Financial to $92 from $84 following quarterly results. The analyst reiterates an Outperform rating on the shares.
05/16/18
GSCO
05/16/18
DOWNGRADE
Target $81
GSCO
Neutral
LPL Financial downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Conor Fitzgerald downgraded LPL Financial (LPLA) to Neutral from Buy and removed the shares from his firm's Americas Conviction List. Following the recent outperformance of the stock, the analyst sees more upside in Raymond James (RJF), a name he upgraded this morning to Buy from Neutral. Fitzgerald keeps an $81 price target on LPL.
04/27/18
FBCO
04/27/18
UPGRADE
Target $103
FBCO
Neutral
Raymond James upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Craig Siegenthaler upgraded Raymond James Financial (RJF) to Neutral from Underperform and raised his price targets on shares to $103 from $99. In a research note to investors, the analyst said he was using yesterday's weaker results to exit the Underperform position, but sees "relative upside" in shares of LPL Financial (LPLA) vs. Raymond James over the next six months. Siegenthaler remains on the sidelines on Raymond James vs. an Overweight rating on other retail brokers.
04/10/18
BERN
04/10/18
INITIATION
Target $75
BERN
Outperform
LPL Financial initiated with an Outperform at Bernstein
As previously reported, Bernstein analyst Christian Bolu started LPL Financial with an Outperform rating and $75 price target as he believes consolidation opportunity and business inflection are underappreciated.
NOW ServiceNow
$184.51

-0.53 (-0.29%)

07/26/18
JMPS
07/26/18
NO CHANGE
Target $220
JMPS
Outperform
ServiceNow price target raised to $220 from $180 at JMP Securities
JMP Securities analyst Greg McDowell said ServiceNow had a "strong" Q2, highlighting its record 28 deals over $1M in net new annual contract value. Noting that the company's revenue, EPS and subscription billings all topped his estimates, McDowell raised his price target on ServiceNow to $220 and keeps an Outperform rating on the stock.
07/26/18
ADAM
07/26/18
NO CHANGE
Target $210
ADAM
Buy
ServiceNow price target raised to $210 from $190 at Canaccord
Canaccord analyst Richard Davis raised his price target on ServiceNow to $210 from $190 following Q2 results. The analyst said there was upside across the board with pretty much every metric on track. He noted the company reiterated its full-year guidance and he expects there is potential upside as the year plays out. Davis reiterated his Buy rating on ServiceNow shares.
07/26/18
JPMS
07/26/18
NO CHANGE
Target $200
JPMS
Neutral
ServiceNow price target raised to $200 from $163 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for ServiceNow to $200 citing the company's "solid" Q2 beat in subscription revenue and billings. The company's outlook is being weighed down by currency, but normalizing for FX, guidance is going up "showing the health of the underlying demand," Auty tells investors in a research note. He keeps a Neutral rating on shares of ServiceNow. The analyst says the company's valuation remains in the upper tiers of software and that he'd like to see a better entry point.
07/26/18
KEYB
07/26/18
NO CHANGE
Target $210
KEYB
Overweight
ServiceNow price target raised to $210 from $194 at KeyBanc
KeyBanc analyst Rob Owens raised his price target for ServiceNow to $210 from $194, while reiterating an Overweight rating on the shares. With another beat and raise quarter on a constant-currency basis, the company's strong large-deal activity, customer additions, and retention rates suggest the story still has room to run, the analyst contends. He reiterates an Overweight rating on the shares.
FG FGL Holdings
$9.33

0.065 (0.70%)

04/25/18
FBCO
04/25/18
INITIATION
Target $11
FBCO
Neutral
FGL Holdings initiated with a Neutral at Credit Suisse
Credit Suisse analyst Andrew Kligerman started FGL Holdings with a Neutral rating and $11 price target as he expects robust earnings growth, but not without risk.
03/02/18
03/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Home Depot (HD), Lowe's (LOW), Tempur Sealy (TPX), Mohawk (MHK), Lumber Liquidators (LL) and Michaels (MIK) initiated with a Hold at Loop Capital. The firm also started Fortune Brands (FBHS) and Wayfair (W) with a Buy. 2. Aflac (AFL), Lincoln National (LNC), Brighthouse Financial (BHF), MetLife (MET) Unum (UNM), Principal Financial (PFG) and Reinsurance Group (RGA) initiated with a Neutral at UBS. The firm also initiated Voya (VOYA) and FGL Holdings (FG) with a Buy and Torchmark (TMK) and American Equity (AEL) with a Sell. 3. HP Enterprise (HPE) initiated with a Neutral at JPMorgan. 4. Caterpillar (CAT), Deere (DE), United Rentals (URI) and Wabco (WBC) initiated with an Overweight, Oshkosh (OSK), Terex (TEX), Cummins (CMI), CNH Industrial (CNHI) and REV Group (REVG) initiated with an Equal Weight and Paccar (PCAR) and Agco (AGCO) initiated with an Underweight at Morgan Stanley. 5. Conatus (CNAT) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/02/18
UBSW
03/02/18
INITIATION
Target $12
UBSW
Buy
FGL Holdings initiated with a Buy at UBS
UBS analyst John Nadel started FGL Holdings with a Buy rating and $12 price target. The analyst believes current share levels provide a good entry point.
07/17/18
RBCM
07/17/18
INITIATION
Target $10
RBCM
Outperform
FGL Holdings initiated with an Outperform at RBC Capital
RBC Capital analyst Kenneth Lee initiated FGL Holdings with an Outperform rating and a price target of $10. The analyst notes that the company is in a transition period after CF Corp's acquisition of the F&G Life assets late last year, but with the help of The Blackstone Group, it can reposition its portfolio as well as expand its distribution and product offerings. Lee believes the transition process offers investors an "attractive opportunity".
NFLX Netflix
$337.49

-3.79 (-1.11%)

08/14/18
COWN
08/14/18
NO CHANGE
Target $400
COWN
Outperform
Netflix CFO change should be smooth transition, says Cowen
Cowen analyst John Blackledge noted Netflix announced its CFO will step down following the search for a replacement. He believes the search is in its early stages and that the transition will be smooth without any foreseeable material change to the business. Blackledge reiterated his Outperform rating and $400 price target on Netflix shares.
08/13/18
KEYB
08/13/18
NO CHANGE
Target $375
KEYB
Overweight
KeyBanc sees minimal disruption for Netflix from CFO exit
KeyBanc analyst Andy Hargreaves says that while the departure of CFO David Wells is a loss, he expects minimal disruption since Netflix's "financial strategy is now well established." Further, the company "should attract excellent candidates that are capable of ramping quickly," Hargreaves tells investors in a research note titled "CFO Departure Should Not Be a Material Negative." The analyst sees little in Wells' departure to change his view of long-term value in Netflix. Hargreaves keeps an Overweight rating on the shares.
08/13/18
IMPC
08/13/18
NO CHANGE
Target $494
IMPC
Outperform
Netflix price target lowered to $494 from $503 at Imperial Capital
Imperial Capital analyst David Miller lowered his price target for Netflix to $494 after slightly reducing his global subscriber estimates. The analyst says that in the "interest of being conservative," he decreased his fiscal 2018 global subscriber estimate to 141.2M from 141.4M and fiscal 2019 global subscriber estimate to 164.4M from 166.3M. Miller, however, keeps an Outperform on the shares. He believes Netflix can afford to be patient with original programming and that "in reality, there is not much competition" for the company.
08/13/18
08/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN SACHS CUTS ALNYLAM TO BUY: Goldman Sachs analyst Terence Flynn downgraded Alnylam (ALNY) to Buy from Conviction Buy. The analyst also lowered his price target for the shares to $155 from $193. Flynn said the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. Piper Jaffray analyst Edward Tenthoff recommended buying shares of Alnylam Pharmaceuticals on weakness following the approval of Onpattro. Morgan Stanley analyst David Lebowitz lowered his price target to $93, Nomura Instinet analyst Christopher Marai lowered his price target to $73, and Stifel analyst Paul Matteis maintained a Buy rating but cut his price target to $123 from $125 and slightly lowered his revenue ramp for the drug based on modestly reduced share in mixed-phenotype haTTR patients and lower share in cardiac-only haTTR patients. B. Riley FBR analyst Madhu Kumar raised his price target to $230. RUBIUS THERAPEUTICS INITIATED AT MULTIPLE FIRMS: Rubius Therapeutics (RUBY) was initiated with an Outperform at Leerink, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies. PIPER JAFFRAY SAYS AMAZON AD BUSINESS GROWING INTO PROFIT DRIVER: Amazon's (AMZN) advertising business "has been quietly growing into a massive driver of current and future profitability," Piper Jaffray analyst Michael Olson told investors in a research note. Applying an advertising comp multiple of 16 times to estimated 2020 Amazon advertising operating income suggests an ad business that should be valued at $150B-$190B, Olson contended. IMPERIAL CAPITAL CUTS NETFLIX PRICE TARGET TO $494: Imperial Capital analyst David Miller lowered his price target for Netflix (NFLX) to $494 after he slightly reduced his global subscriber estimates. The analyst said that in the "interest of being conservative," he decreased his fiscal 2018 global subscriber estimate to 141.2M from 141.4M and fiscal 2019 global subscriber estimate to 164.4M from 166.3M. DISH DOWNGRADED TO SELL AT MOFFETTNATHANSON: MoffettNathanson analyst Craig Moffett downgraded Dish (DISH) to Sell from Neutral with a price target of $29 and noted that while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse.
EQT EQT Corporation
$50.34

0.98 (1.99%)

08/06/18
MSCO
08/06/18
NO CHANGE
Target $59
MSCO
Equal Weight
Mountain Vally stop order ups risk for more delays for EQT, says Morgan Stanley
After the Federal Energy Regulatory Commission issued a project-wide stop work order for the Mountain Valley Pipeline project, which is partially owned by EQT Midstream Partners (EQM), Morgan Stanley analyst Drew Venker said this shouldn't be a big surprise given key permits had been vacated, but he also believes it does increase the risk of further project delays. Venker, who continues to expect in service in full for the Mountain Valley Pipeline is most likely between Q2 and Q3 of 2019, keeps an Equal Weight rating and $59 price target on EQT Corporation (EQT) shares.
07/05/18
TDSI
07/05/18
INITIATION
Target $57
TDSI
Hold
EQT Corporation initiated with a Hold at TD Securities
TD Securities analyst Menno Hulshof initiated EQT Corporation with a Hold and $57 price target.
06/13/18
JPMS
06/13/18
NO CHANGE
Target $70
JPMS
Overweight
EQT midstream separation a catalyst for shares, says JPMorgan
JPMorgan analyst Arun Jayaram believes the separation of EQT Corporation's exploration and production and midstream segments is on track for completion during Q2, which should be a "catalyst to narrow the sum-of-the parts discount." After "re-running a lot of math," the analyst continues to see a "compelling idiosyncratic trading opportunity" in the stock given the discounted valuation, balance sheet strength, and attractive combination of growth and free cash flow generation. He keeps an Overweight rating on EQT with a $70 price target.
07/05/18
07/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Deciphera (DCPH) initiated with a Buy at SunTrust. 2. EQT Corporation (EQT) initiated with a Hold at TD Securities. 3. Pioneer Natural (PXD) initiated with a Buy at TD Securities. 4. Veoneer (VNE) initiated with an Overweight at Barclays. 5. Valeritas (VLRX) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
WMB Williams
$30.32

-0.36 (-1.17%)

05/21/18
STFL
05/21/18
DOWNGRADE
STFL
Hold
Williams Partners downgraded to Hold from Buy at Stifel
Stifel analyst Selman Akyol downgraded Williams Partners (WPZ) to Hold from Buy to reflect the announcement of a rollup into Williams Companies (WMB).
08/07/18
STFL
08/07/18
INITIATION
Target $35
STFL
Buy
Williams initiated with a Buy at Stifel
Stifel analyst Selman Akyol initiated Williams Companies (WMB) with a Buy rating and $35 price target, as he anticipates investment opportunities for the Transco Pipeline, which is the largest natural gas pipeline in the country, will extend well into the next decade. He believes Williams, which will be the only remaining publicly traded Williams entity after shareholders vote on a merger with Williams Partners (WPZ) on August 9, offers investors a 16% total return potential, including a 4.3% current yield.
07/25/18
SPHN
07/25/18
DOWNGRADE
Target $48
SPHN
Equal Weight
Williams Partners downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Matt Schmid downgraded Williams Partners (WPZ) to Equal Weight from Overweight to reflect the pending acquisition by Williams (WMB). He raised his price target on Williams Partners to $48 from $43 to adjust for the acquisition exchange ratio.
07/18/18
JEFF
07/18/18
NO CHANGE
Target $34
JEFF
Buy
Jefferies replaces Oneok with Williams on Franchise Pick List
Jefferies analyst Christopher Sighinolfi replaced Oneok (OKE), a stock he downgraded this morning, with Williams (WMB) on his firm's Franchise Pick List. The analyst has a Buy rating on Williams with a $34 price target.

TODAY'S FREE FLY STORIES

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change  »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change  »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change  »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.